JAQINUS Trademark

Trademark Overview


On Friday, August 19, 2011, a trademark application was filed for JAQINUS with the United States Patent and Trademark Office. The USPTO has given the JAQINUS trademark a serial number of 85402233. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 8, 2012. This trademark is owned by Pfizer Inc.. The JAQINUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use
jaqinus

General Information


Serial Number85402233
Word MarkJAQINUS
Filing DateFriday, August 19, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 8, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 10, 2012

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of "JAQINUS" with bursting design.
Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 24, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Tuesday, October 9, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 8, 2012ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 6, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 10, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2012PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 2, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 30, 2011ASSIGNED TO EXAMINER
Thursday, August 25, 2011NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, August 24, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 23, 2011NEW APPLICATION ENTERED IN TRAM